Fresenius Kabi Australia Pty Ltd
Regulatory activities for this sponsor.
Loading...
Sponsor content
6 result(s) found, displaying 1 to 6
-
Australian Public Assessment Report (AusPAR)New AusPAR for Dipeptiven (alanylglutamine) to treat patient in hypercatabolic and/or hypermetabolic states as part of parenteral nutrition.
-
Australian Public Assessment Report (AusPAR)Australian Public Assessment Report for Adalimumab
-
Australian Public Assessment Report (AusPAR)Australian Public Assessment Report for Sodium glycerophosphate (as hydrate)
-
Australian Public Assessment Report (AusPAR)Australian Public Assessment Report for Nine trace elements including chromic chloride
-
Australian Public Assessment Report (AusPAR)Australian Public Assessment Report for SMOFlipid 20% / Aminoven 10% (with or without electrolytes) / glucose 42%
-
Australian Public Assessment Report (AusPAR)Australian Public Assessment Report for Soyal oil / Medium chain triglycerides / Olive oil / Fish oil